At what enterprise value was COLISÉE acquired in 2014?

During the acquisition of COLISÉE by EURAZEO in 2014, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of COLISÉE when it was acquired by EURAZEO?

The estimated EV/EBITDA multiple for COLISÉE is in the range of 5x - 12x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was COLISÉE acquired by EURAZEO?

COLISÉE was acquired by EURAZEO in 2014.

What was the revenue of COLISÉE at the time of the deal?

The revenue of COLISÉE at the time of the deal is estimated to be in the range of 100M - 200M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of COLISÉE during the acquisition?

COLISÉE's EBITDA is estimated to be in the range of 5M - 25M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the COLISÉE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the COLISÉE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.fusacq.com/buzz/eurazeo-pme-acquiert-le-groupe-colisee-4eme-acteur-francais-du-secteur-des-ehpad-a80804_ca_

← DATABASE

Home Database Healthcare & PharmaCOLISÉE

09/2014

EURAZEO takes majority stake in COLISÉE

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV 100M - 350M EUR

Context

The acquisition of Groupe Colisée by Eurazeo PME is a strategic move that aligns with the firm's investment strategy of supporting companies that are well-positioned to benefit from underlying societal trends. With the aging population and increasing demand for elderly care services, Groupe Colisée is well-positioned for growth and expansion. Eurazeo PME's investment in Groupe Colisée is intended to support the group's continued development and consolidation of the French retirement home market, as well as its expansion into new markets, including China. The acquisition is also expected to enable Groupe Colisée to strengthen its services and offerings, particularly in terms of dependency care, and to further enhance its reputation for quality and excellence. By partnering with Eurazeo PME, Groupe Colisée aims to capitalize on the growing demand for elderly care services and to establish itself as a leading player in the French and international markets.

COLISÉE, which reported an EBITDA margin of LOGIN in 2014, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Colisée is the fourth largest French EHPAD operator, founded in 1976 and chaired by Christine Jeandel. The group operates numerous establishments across France, Spain, Belgium, Italy, and China. Colisée has grown significantly through an active buy-and-build strategy. Colisée is recognised as one of the leading pan-European elderly care platforms, combining a strong French domestic base with meaningful international operations across Southern Europe and Asia.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2014

2013

Other operations with COLISÉE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
09/2020	EQT PARTNERS	COLISÉE	FRANCE	Health Providers	EQT Infrastructure entered into exclusive negotiations with IK Investment Partners to acquire a majority stake in Colisée, marking a transition from private equity to infrastructure ownership. IK had previously acquired Colisée in 2017 from Eurazeo PME and the founding family
04/2019	COLISÉE	ARMONEA	BELGIUM	Health Providers	Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries
04/2017	EQT PARTNERS	COLISÉE	FRANCE	Health Providers	IK Investment Partners, through its IK VIII Fund, reached an agreement with Eurazeo PME and the management team to acquire a majority stake in Colisée. The founding family and management team reinvested alongside IK, ensuring continuity of strategic direction and operational leadership

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of COLISÉE by EURAZEO are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: eurazeo